Exercise Echocardiography in Hypertrophic Cardiomyopathy
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2014, Vol 1, Issue 2
Abstract
Hypertrophic cardiomyopathy (HCM) is a relatively frequent genetic disease that affects 1/500 human beings. Main problems with this disease are the development of symptoms in 10-20% of affected individuals, and the increased risk of sudden cardiac death (SCD) in a subset of patients with the disease. It is important to clarify the cause of symptoms and to assess the risk of sudden death in HCM because we do have therapies to relief these problems.
Authors and Affiliations
Jesús Peteiro, Alberto Bouzas- Mosquera
Infective Endocardatis at the Yaounde General Hospital: Clinical aspects and outcome (Case Series)
Introduction: Infectious endocarditis (IE) is a severe pathology. Its epidemiological, clinical and evolutive profile varies a lot depending if it is in the context of a developed country or developing country. In our co...
MINI-OPCABG an option in Hybrid coronary revascularization
Hybrid coronary revascularization (HCR) combines minimally invasive left internal mammary artery to left anterior descending bypass with percutaneous coronary intervention of non-left anterior descending vessels. And it...
Supraventricular Tachycardia: From Catheter to Catheter Ablation
I had a privilege of having a really attentive and good medical student rotating through my cardiology office for a month. One day I explained to her in greater details that in spite of all the tests, devices and everyth...
Hydrogels for Cardiac Tissue Repair and Regeneration
The main cause of death in the world continues to be cardiovascular disease, which affects annually over 900,000 people and in the entire word approximately 50% of the people suffering myocardial infarction (MI) die with...
Can Irisin be a New Agent Responsible for the Development of Heart Attack and Cardiac Cachexia?
Cardiac cachexia, a syndrome characterized by systemic destruction, nutritional impairment and weight loss [1], has a prevalence ranging between 8 and 42% around the world [2]. The syndrome was first described by the fat...